Table 4.
Treatment | IL-17A | LPS + IL-35 |
Cells | HAECs, PBMCs | HAECs, PBMCs |
Experimental design (trait) | Time course | Dose response |
Result | IL-17 significantly increased monocyte adhesion in a time dependent manner and promoted EC activation | IL-35 inhibited LPS-induced leukocyte adhesion to ECs in a dose dependent manner |
EC status | Increases EC activation | Inhibits LPS-induced EC activation |
PMID | 26733204 | 26085094 |
EC endothelial cells, HAECs human aortic endothelial cells, IL interleukin, LPS lipopolysaccharide, PBMCs peripheral blood mononuclear cells